| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Negotiation > Conversational Debate Trickery and Common Courtesy Issues |
|
Main Subject - Conversational Debate Trickery and Common Courtesy Issues
When debating with someone else who begins using normal human conversational trickery, often they w According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ill demand common courtesy if the debate gets heated. Although in reality no one should not expect ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in any common courtesy who uses such tactics, as they move to make the other party look foolish, eat t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. heir words or backtrack on a previous comment. This is because as you disrespect the other party, here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hey want revenge. And common courtesy simply goes out the window. Recently in debating a topic with d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro a Poker Player who is involved in the online gambling business. He attempted to use such tactics, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc so I explained this to him; You see, obviously if one is a decent poker card player they do unders easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi and all this, so indeed your questioning stating: “I don’t Understand” is also no nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t common courtesy, because you pretend not to understand something that you think you know, that yo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ u really don’t know, in order to make a point. Thus hoping to bait the other person (me), whi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi h I do not appreciate, into burying themselves into proving your point. This is conversational tric ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a kery often used in debate. Unfortunately, you are debating with someone who has now schooled you i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n reality of this subject matter and are now burying yourself. Further, these types of manipulation cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s in conversation you are using really are not a very nice way to correspond, because you are tryin tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen belittle the next guy and yet all the while in this debate; You Demand Common Courtesy? Therefore t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel your tactics and demands are disrespectful and inadequate. So as long as one is Demanding Somethin ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust g from me without proper reciprocal response, well, I cannot give it too you, I do not feel common y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ourtesy is owed from me, but you may find others, will in the future, after all you might be a of t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de heir customers or they might want something from you. Personally, I don’t gamble, the risk do elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip es not make sense mathematically. That is what I think. Perhaps you might consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Franchising is Virtually Fraud Free Eliminate the Cost, Hassle and Time Associated With Printing and Distributing Enterprise Reports Real Estate Postcard Marketing: Postcards + Website = Leads
|